--- title: Buy Ofev (Nintedanib) 100mg Caps Online description: Ofev (Nintedanib) 100mg capsules slow IPF progression. Order from our verified pharmacy for authentic treatment options. type: product language: en url: https://ayudadiabetes.com/order-ofev-online-en availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 192.99 price_max: 1378.99 currency: USD offers: - name: 100mg x 30 caps price: 192.99 - name: 100mg x 60 caps price: 329.99 - name: 100mg x 90 caps price: 454.99 - name: 100mg x 120 caps price: 550.99 - name: 100mg x 180 caps price: 1378.99 --- # Buy Ofev (Nintedanib) 100mg Caps Online Ofev, with Nintedanib, is a kinase inhibitor developed by Boehringer Ingelheim for idiopathic pulmonary fibrosis (IPF) in adults. It targets pathways involved in fibrosis to slow lung function decline. For patients diagnosed with IPF. Get Ofev in 100mg caps online. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **100mg** | 30 caps | **$192.99** | $6.43 | In Stock | | **100mg** | 60 caps | **$329.99** | $5.50 | In Stock | | **100mg** | 90 caps | **$454.99** | $5.06 | In Stock | | **100mg** | 120 caps | **$550.99** | $4.59 | In Stock | | **100mg** | 180 caps | **$1378.99** | $7.66 | In Stock | [Buy Now](https://ayudadiabetes.com/order-ofev-online-en) ## Introduction Ofev contains the active ingredient nintedanib and is supplied as oral capsules of 100 mg. It belongs to the class of tyrosine-kinase inhibitors and is approved for the treatment of progressive fibrotic lung diseases. The medication is primarily used to slow the decline in lung function in patients with idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD). ## Quick Reference Facts **Active Ingredient** : Nintedanib **Form** : cap 100 mg **Primary and Off-Label Uses** : Idiopathic pulmonary fibrosis : Systemic sclerosis-associated interstitial lung disease : Chronic fibrosing interstitial lung diseases ## What is Ofev? Ofev is a branded formulation of nintedanib, a small-molecule inhibitor of multiple receptor tyrosine kinases involved in tissue remodelling. It is marketed by Boehringer Ingelheim and received its first European Union approval in 2014 for idiopathic pulmonary fibrosis. Although Ofev itself is a brand product, generic versions of nintedanib are available and may offer a lower-cost alternative for patients with a valid prescription. ## How Ofev Works Nintedanib blocks the intracellular signalling of platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) receptors. These pathways drive fibroblast proliferation, extracellular-matrix deposition and angiogenesis, all central processes in the development of lung fibrosis. By inhibiting these receptors, Ofev reduces the activation of fibroblasts and limits collagen accumulation, thereby slowing the progressive loss of lung capacity. The drug reaches peak plasma concentrations within 2-4 hours after oral intake and is extensively metabolised in the liver, mainly via ester hydrolysis followed by glucuronidation. Its elimination half-life is approximately 9.5 hours, supporting a twice-daily dosing regimen. ## Conditions Treated with Ofev - **Idiopathic Pulmonary Fibrosis (IPF)** - IPF is a chronic, progressive scarring of the lung tissue with no known cause. Nintedanib attenuates the rate of forced vital capacity (FVC) decline, helping patients retain functional breathing capacity for a longer period. - **Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)** - In systemic sclerosis, autoimmune-driven inflammation leads to lung fibrosis. Clinical trials have shown that nintedanib reduces the annual rate of FVC loss in this population, providing a disease-modifying option alongside immunosuppressive therapy. - **Other Chronic Fibrosing Interstitial Lung Diseases** - Regulatory agencies have extended approval to a broader group of fibrotic lung conditions that share a similar pathogenic mechanism, offering patients a unified therapeutic approach when disease progression is evident. ## Is Ofev the Right Medication for You? Ofev is indicated for adults with a confirmed diagnosis of IPF or SSc-ILD who demonstrate a progressive decline in lung function despite optimal supportive care. Ideal candidates are those with measurable FVC reduction over the preceding 12 months and without contraindicating comorbidities. The drug is especially valuable when clinicians aim to preserve quality of life and delay the need for supplemental oxygen or lung transplantation. Contraindications include severe hepatic impairment, known hypersensitivity to nintedanib or any excipients, and concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole). Caution is advised in patients with a history of cardiovascular disease, bleeding disorders, or gastrointestinal ulceration, as these conditions may be exacerbated by the medication’s side-effect profile. ## Buying Ofev from [our online pharmacy](https://ayudadiabetes.com/order-ofev-online-en) ### Why Choose Our Service? Accessing specialised medicines can be challenging through conventional pharmacies, especially when supply constraints or high retail prices apply. Our platform provides a discreet, reliable route to obtain Ofev without the typical hurdles, allowing patients to focus on their treatment rather than logistics. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is verified against the manufacturer’s specifications and sourced from facilities that comply with recognised regulatory frameworks. ### Pricing & Access By sourcing directly from recognised overseas suppliers, we can offer Ofev at a price close to the manufacturer’s cost, substantially lower than many local retailers. This model also makes the medication available to patients residing in regions where it may be intermittently out of stock. ### Discreet Delivery Orders are packed in unmarked envelopes and dispatched via secure carriers. Standard shipping typically arrives within seven days, while the optional express option ensures delivery in under three weeks, all while preserving patient privacy. ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing** - The usual regimen is one 100 mg capsule taken orally twice daily, spaced at least 12 hours apart. Dose adjustments may be required based on tolerability, liver function, or drug interactions. - **Missed Dose** - If a dose is forgotten, take it as soon as you remember provided at least six hours have not elapsed since the scheduled time. Do not double-dose to compensate for a missed tablet. - **Overdose** - In the event of a suspected overdose, seek immediate medical attention. Symptoms may include severe nausea, vomiting, diarrhoea, or elevated liver enzymes. Supportive care, including gastric decontamination and monitoring of hepatic function, is the mainstay of management. - **Practical Precautions** - Ofev should be swallowed whole with food or a light snack to minimise gastrointestinal irritation. Alcohol consumption can increase the risk of liver toxicity and should be limited. Patients should avoid operating heavy machinery until they know how the drug affects them, as dizziness and fatigue are possible. ## Safety Information ### ⚠️ Who Should Not Take Ofev - Patients with severe hepatic impairment (Child-Pugh C). - Individuals with known hypersensitivity to nintedanib or any capsule excipient. - Concurrent use of potent CYP3A4 inhibitors (e.g., itraconazole, clarithromycin). ### Common Side Effects - **Gastrointestinal:** Diarrhoea, nausea, abdominal pain (reported in >30% of patients). Often manageable with dose reduction or antidiarrhoeal agents. - **Hepatic:** Mild to moderate elevations in transaminases; liver function should be monitored every 3 months. - **General:** Headache, decreased appetite, and fatigue. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe Hepatotoxicity:** Jaundice, dark urine, persistent fatigue, or markedly raised liver enzymes. - **Bleeding:** Gastrointestinal haemorrhage or unexplained bruising, particularly in patients on anticoagulants. - **Cardiovascular Events:** New onset chest pain, palpitations, or signs of myocardial ischaemia. ### Drug & Food Interactions - **CYP3A4 Inhibitors (e.g., ketoconazole):** May increase nintedanib plasma concentrations; dose reduction recommended. - **CYP3A4 Inducers (e.g., rifampicin):** May lower drug exposure, potentially reducing efficacy. - **Anticoagulants/Antiplatelet agents:** Enhanced bleeding risk; monitor coagulation parameters. ## Off-Label and Investigational Uses of Ofev - **Chronic Obstructive Pulmonary Disease (COPD) with Emphysema:** Early phase studies suggest nintedanib may attenuate emphysematous progression, though efficacy data remain limited. - **Pulmonary Hypertension associated with interstitial lung disease:** Some investigators have explored its anti-angiogenic properties as a therapeutic avenue, but formal approval is absent. These applications are not approved by the MHRA or EMA; clinicians may consider them only within clinical-trial settings or after thorough risk-benefit assessment. ## Storage & Handling - Store capsules at 20-25 °C (68-77 °F) in the original container, protected from moisture and light. - Do not refrigerate or freeze. - Keep out of reach of children. - Dispose of unused medication according to local hazardous-waste guidelines or return to a pharmacy for safe destruction. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Ofev?** Yes, but keep the medication in its original packaging with a copy of the prescription to satisfy customs regulations. - **Should I take Ofev with food?** Taking the capsule with a low-fat meal reduces the likelihood of stomach upset and improves tolerability. - **Is it safe to combine Ofev with over-the-counter herbal supplements?** Some supplements (e.g., St John’s wort) affect CYP3A4 activity and could alter nintedanib levels. Discuss any supplement use with a pharmacist. **Product Information** - **What do Ofev capsules look like?** They are white, film-coated capsules bearing the imprint “100 mg Ofev” in black lettering. - **Can the capsule be split for dose adjustment?** No. The film coating ensures proper release; breaking the capsule may lead to dose variability and reduced efficacy. **Regulatory & Safety Nuances** - **Will Ofev show up on a standard drug test?** Nintedanib is not typically screened for in routine workplace drug panels. - **Is Ofev safe for pregnant or breastfeeding women?** The drug is category D in the UK, indicating potential risk to the fetus. Women who are pregnant, planning pregnancy, or nursing should avoid Ofev unless the benefit clearly outweighs the risk. - **Do elderly patients need dose adjustments?** No automatic reduction is required, but clinicians should monitor for increased sensitivity to side effects, particularly gastrointestinal and hepatic effects. **Scientific & Clinical Curiosity** - **What was the pivotal trial that led to Ofev’s approval?** The INPULSIS-1 and INPULSIS-2 phase III studies demonstrated a 50 % reduction in annual FVC decline compared with placebo in IPF patients. - **How does Ofev differ from earlier antifibrotic agents?** Unlike pirfenidone, which has an unclear target, nintedanib directly inhibits multiple tyrosine-kinase receptors, offering a broader anti-fibrotic mechanism. ## Glossary **Tyrosine-Kinase Inhibitor** : A class of drugs that block enzymes (tyrosine kinases) involved in cell signalling pathways that promote tissue growth and fibrosis. **Forced Vital Capacity (FVC)** : The maximal amount of air a person can exhale forcefully after a full inhalation; a key measure of lung function in fibrotic diseases. **Hepatic Enzyme Induction** : The process by which a substance increases the activity of liver enzymes, potentially lowering the plasma levels of co-administered drugs. **CYP3A4** : A major liver enzyme responsible for metabolising a wide variety of medications; its activity can be altered by other drugs or foods. **Bioavailability** : The proportion of an administered dose that reaches systemic circulation in an active form. ## Disclaimer The information provided about **Ofev** is intended for general educational purposes and does not replace professional medical consultation. All therapeutic decisions, including those involving off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed choices about their health. Our pharmacy service offers access to **Ofev** for individuals who may encounter limited availability through conventional channels or who seek cost-effective alternatives. Always discuss with your doctor before initiating, modifying, or discontinuing any medication.